“…In-vivo labeling of monocytes/macrophages with iron-oxide particles for MRI has been applied to image many disease conditions, such as graft rejection, atherosclerotic plaques, tumors, abdominal aortic aneurysm, renal ischemia, and Alzheimer’s disease [2,10,25,27,28,29,30,31,32,33]. Our laboratory has been able to monitor the infiltration of macrophages labeled with USPIO or MPIO particles at rejecting kidneys, hearts, and lungs in our rat models for organ transplantation using the in-vivo labeling procedure [2,10,25,53,54].…”